Trump posted on Twitter around 1 a.m. Friday that he and first lady Melania Trump had tested positive for the coronavirus, and the White House announced Friday afternoon he had been treated with Regeneron’s experimental antibody therapy.

But during a briefing just before noon on Saturday, Conley said that Trump was “just 72 hours into the diagnosis now,” which would have put his diagnosis at midday Wednesday. Another physician, Dr. Brian Garibaldi, said Trump was treated with an experimental antibody therapy “about 48 hours ago,” which would have been midday Thursday.

The doctors did not address the timing discrepancies during the briefing, but Saturday afternoon, Conley released a memo aimed at clarifying the timeline.

“This morning while summarizing the President’s health, I incorrectly used the term ‘seventy two hours’ instead of ‘day three’ and ‘fourth eight hours’ instead of ‘day two’ with regards to his diagnosis and the administration of the polyclonal antibody therapy.

“The President was first diagnosed with COVID-19 on the evening of Thursday, October 1st and had received Regeron’s antibody cocktail on Friday, October 2nd.”

The memo had misspellings, including the name of Regeneron, the name of the company that makes the treatment Trump received. A spokesperson for Regeneron told CNN that the treatment was a monoclonal antibody treatment, not a polyclonal antibody treatment. The memo also did not note that the 48-hour remark was made by Garibaldi, not Conley.

Advisers made last-minute push to get reluctant Trump to Walter Reed
A positive Covid-19 test midday Wednesday and use of an experimental treatment midday Thursday would move up significantly the timeline of Trump’s illness.

On Tuesday night, Trump participated in the first presidential debate. Cleveland Clinic, which hosted the debate, confirmed to CNN that it required everyone in the debate hall to have a negative Covid-19 test, but did not say when tests needed to be taken, what tests were used or how campaigns were required to disclose test results.

On Wednesday, Trump visited Minnesota. And on Thursday — after Trump aide Hope Hicks had developed symptoms — the President attended a Bedminster, New Jersey, fundraiser that included an indoor roundtable, an indoor VIP reception with a socially distant photo-op and outdoor reception.

A confusing timeline

White House sows confusion about Trump's condition as source tells reporters next 48 hours will be critical

Despite saying Trump was 72 hours into his diagnosis, Conley also said during Saturday’s briefing at Walter Reed National Military Medical Center that Trump tested positive for coronavirus late Thursday night. Conley would not say when Trump’s last negative Covid-19 test took place.

“I’m not going to get into all the testing going back,” Conley said during the Saturday briefing. “But he and all the staff … routinely are tested.”

When asked about the 72-hour remark, Conley said, “So Thursday afternoon following the news of a close contact is when we repeated testing.

“And given kind of clinical indications we had a little bit more concern. And late that night we got the PCR confirmation that he was…” Conley said, trailing off.

During the same Saturday briefing, Garibaldi, one of the team of doctors treating Trump at the Walter Reed, told reporters Trump was treated with an experimental antibody therapy “about 48 hours ago,” which would have been midday Thursday.

“About 48 hours ago, the President received a special antibody therapy directed against the coronavirus,” Garibaldi said just before noon on Saturday.

Conley had said in a memo released Friday afternoon, “Following PCR-confirmation of the President’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail.” The memo did not specify when the PCR confirmation took place.

Regeneron has confirmed it provided a single 8-gram dose of its antibody therapy to be used by Trump, but did not specify when it received the request.

CNN’s Jen Christensen and Jason Hoffman contributed to this report.

Source Article